600 related articles for article (PubMed ID: 31778219)
21. Changes in the result of antinuclear antibody immunofluorescence assay on HEp-2 cells reflect disease activity status in systemic lupus erythematosus.
Prado MS; Dellavance A; Rodrigues SH; Marvulle V; Andrade LEC
Clin Chem Lab Med; 2020 Jul; 58(8):1271-1281. PubMed ID: 32623848
[TBL] [Abstract][Full Text] [Related]
22. Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.
Torell A; Stockfelt M; Blennow K; Zetterberg H; Akhter T; Leonard D; Rönnblom L; Pihl S; Saleh M; Sjöwall C; Strevens H; Jönsen A; Bengtsson AA; Trysberg E; Majczuk Sennström M; Zickert A; Svenungsson E; Gunnarsson I; Bylund J; Jacobsson B; Rudin A; Lundell AC
Arthritis Res Ther; 2024 Mar; 26(1):65. PubMed ID: 38459582
[TBL] [Abstract][Full Text] [Related]
23. [THE CLINICAL INFORMATIVENESS OF AUTOMATED METHODS OF SCREENING DETECTION OF ANTI-NUCLEAR ANTIBODIES USING INDIRECT REACTION OF IMMUNE FLUORESCENCE, ENZYME-LINKED IMMUNOSORBENT ASSAY AND MULTIPLEX XMAP TECHNOLOGY UNDER SYSTEMIC LUPUS ERYTHEMATOSUS].
Verizhnikova ZG; Aleksandrova EN; Novikov AA; Panafidina TA; Seredavkina NV; Popkova TV; Aizina NL; Nasonov EL
Klin Lab Diagn; 2017 Mar; 62(3):173-7. PubMed ID: 30620533
[TBL] [Abstract][Full Text] [Related]
24. Anti-double stranded antibody. Association with titers and fluorescence patterns of anti-nuclear antibody in systemic lupus erythematosus.
Almogren A
Saudi Med J; 2010 Jan; 31(1):32-6. PubMed ID: 20062896
[TBL] [Abstract][Full Text] [Related]
25. Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus.
Wu Y; Cai B; Feng W; Yang B; Huang Z; Zuo C; Wang L
Indian J Med Res; 2014 Oct; 140(4):513-9. PubMed ID: 25488445
[TBL] [Abstract][Full Text] [Related]
26. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
Hoffman IE; Peene I; Meheus L; Huizinga TW; Cebecauer L; Isenberg D; De Bosschere K; Hulstaert F; Veys EM; De Keyser F
Ann Rheum Dis; 2004 Sep; 63(9):1155-8. PubMed ID: 15308527
[TBL] [Abstract][Full Text] [Related]
27. Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.
Touloupi E; Routsias JG; Tzioufas AG
Clin Exp Immunol; 2005 Oct; 142(1):172-9. PubMed ID: 16178873
[TBL] [Abstract][Full Text] [Related]
28. ANA negative systemic lupus erythematosus sera revisited serologically.
Reichlin M
Lupus; 2000; 9(2):116-9. PubMed ID: 10787008
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus.
Atta AM; Santiago MB; Guerra FG; Pereira MM; Sousa Atta ML
Int Arch Allergy Immunol; 2010; 152(4):401-6. PubMed ID: 20197682
[TBL] [Abstract][Full Text] [Related]
30. Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Ramsey-Goldman R; Alexander RV; Massarotti EM; Wallace DJ; Narain S; Arriens C; Collins CE; Saxena A; Putterman C; Kalunian KC; O'Malley T; Dervieux T; Weinstein A
Arthritis Rheumatol; 2020 Jan; 72(1):78-88. PubMed ID: 31469249
[TBL] [Abstract][Full Text] [Related]
31. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of antinuclear associated antibodies in circulating immune complexes is more prominent in SLE patients from Sudan than Sweden.
Elbagir S; Sohrabian A; Elshafie AI; Elagib EM; Mohammed NEA; Nur MAM; Svenungsson E; Gunnarsson I; Rönnelid J
Sci Rep; 2020 Dec; 10(1):21126. PubMed ID: 33273662
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin E and systemic lupus erythematosus.
Atta AM; Sousa CP; Carvalho EM; Sousa-Atta ML
Braz J Med Biol Res; 2004 Oct; 37(10):1497-501. PubMed ID: 15448870
[TBL] [Abstract][Full Text] [Related]
34. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
[TBL] [Abstract][Full Text] [Related]
35. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
[TBL] [Abstract][Full Text] [Related]
36. Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease.
Villalta D; Bizzaro N; Bassi N; Zen M; Gatto M; Ghirardello A; Iaccarino L; Punzi L; Doria A
PLoS One; 2013; 8(8):e71458. PubMed ID: 23951169
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases.
Aragón CC; Posso-Osorio I; Puerta G; González JD; Naranjo JC; Echeverri A; Ortíz E; Nieto-Aristizábal I; Barrera MC; Ríos-Serna LJ; Tobón GJ
Clin Rheumatol; 2020 Jul; 39(7):2163-2169. PubMed ID: 32086623
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Choi MY; Clarke AE; Urowitz M; Hanly J; St-Pierre Y; Gordon C; Bae SC; Romero-Diaz J; Sanchez-Guerrero J; Bernatsky S; Wallace DJ; Isenberg D; Rahman A; Merrill JT; Fortin PR; Gladman DD; Bruce IN; Petri M; Ginzler EM; Dooley MA; Ramsey-Goldman R; Manzi S; Jönsen A; Alarcón GS; van Vollenhoven RF; Aranow C; Mackay M; Ruiz-Irastorza G; Lim S; Inanc M; Kalunian K; Jacobsen S; Peschken C; Kamen DL; Askanase A; Buyon JP; Costenbader KH; Fritzler MJ
Ann Rheum Dis; 2022 Aug; 81(8):1143-1150. PubMed ID: 35338033
[TBL] [Abstract][Full Text] [Related]
39. Negative ANA-IIF in SLE patients: what is beyond?
Abozaid HSM; Hefny HM; Abualfadl EM; Ismail MA; Noreldin AK; Eldin ANN; Goda AM; Ali AH
Clin Rheumatol; 2023 Jul; 42(7):1819-1826. PubMed ID: 37016193
[TBL] [Abstract][Full Text] [Related]
40. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
